Copyright
©2008 The WJG Press and Baishideng. All rights reserved.
World J Gastroenterol. Sep 7, 2008; 14(33): 5133-5137
Published online Sep 7, 2008. doi: 10.3748/wjg.14.5133
Published online Sep 7, 2008. doi: 10.3748/wjg.14.5133
Roles of galectins in inflammatory bowel disease
Akira Hokama, Department of Medicine and Therapeutics (First Department of Internal Medicine), Control and Prevention of Infectious Disease, Faculty of Medicine, University of the Ryukyus, Okinawa 903-0215, Japan
Emiko Mizoguchi, Gastrointestinal Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, United States; Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital, Harvard Medical School, Boston MA 02114, United States
Atsushi Mizoguchi, Experimental Pathology Unit, Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston MA 02114, United States; Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital, Harvard Medical School, Boston MA 02114, United States
Author contributions: Hokama A, Mizoguchi E, and Mizoguchi A contributed in writing and reviewing the paper.
Supported by National Institute of Health Grants, No. DK64289 and DK74454; IBD grants from the Eli and Edythe L. Broad Medical Foundation; National Institute of Health grant, DK64351; IBD grants from the Eli and Edythe L. Broad Medical Foundation
Correspondence to: Akira Hokama, Department of Medicine and Therapeutics (First Department of Internal Medicine), Control and Prevention of Infectious Disease, Faculty of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa 903-0215, Japan. hokama-a@med.u-ryukyu.ac.jp
Telephone: +81-98-8951144 Fax: +81-98-8951414
Received: April 9, 2008
Revised: July 20, 2008
Accepted: July 27, 2008
Published online: September 7, 2008
Revised: July 20, 2008
Accepted: July 27, 2008
Published online: September 7, 2008
Core Tip